MR-proANP and AM are potentially interesting biomarkers in pre-eclampsia, as they are likely to reflect the hemodynamic and cardiovascular changes and endothelial dysfunction that occur in pre-eclampsia. The gene discussed is NR3C2; the disease is endothelial dysfunction.